TuHURA Biosciences, Inc.
HURA
$2.46
-$0.16-6.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -6.66M | -6.00M | -- | -4.84M | |
| Total Depreciation and Amortization | 14.10K | 17.60K | -- | 34.30K | |
| Total Amortization of Deferred Charges | -- | 171.40K | -- | 17.40K | |
| Total Other Non-Cash Items | 1.42M | 1.08M | -- | 322.50K | |
| Change in Net Operating Assets | 487.20K | 2.13M | -- | 633.70K | |
| Cash from Operations | -4.74M | -2.60M | -- | -3.83M | |
| Capital Expenditure | -42.70K | -21.40K | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -1.11M | -5.99M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 5.19M | -- | -- | |
| Cash from Investing | -1.15M | -823.50K | -- | -- | |
| Total Debt Issued | -- | 0.00 | -- | 4.90M | |
| Total Debt Repaid | -550.00K | -796.90K | -- | -- | |
| Issuance of Common Stock | 504.20K | 13.80K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -2.10K | -- | -- | -- | |
| Other Financing Activities | -500.00K | -2.73M | -- | -272.30K | |
| Cash from Financing | -547.90K | -3.52M | -- | 4.63M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -6.44M | -6.94M | -- | 796.50K | |